ISLE
Income statement / Annual
Last year (2021), Isleworth Healthcare Acquisition Corp.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2021, Isleworth Healthcare Acquisition Corp.'s net income was $10.58 M.
See Isleworth Healthcare Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
FY-2010
|
FY-2009
|
FY-2008
|
FY-2007
|
| Period Ended |
12/31/2021 |
04/24/2016 |
04/26/2015 |
04/27/2014 |
04/28/2013 |
04/29/2012 |
04/24/2011 |
04/25/2010 |
04/26/2009 |
04/27/2008 |
| Operating Revenue |
$0.00
|
$978.59 M
|
$996.28 M
|
$954.60 M
|
$965.20 M
|
$977.37 M
|
$1.01 M
|
$999,000.00
|
$1.12 M
|
$1.13 B
|
| Cost of Revenue |
$0.00 |
$180,000.00 |
$188,000.00 |
$179.42 M |
$175,000.00 |
$169,000.00 |
$179,000.00 |
$179,000.00 |
$193,000.00 |
$182.02 M |
| Gross Profit |
$0.00 |
$978.41 M |
$996.09 M |
$775.18 M |
$965.02 M |
$977.20 M |
$826,000.00 |
$820,000.00 |
$925,000.00 |
$943.33 M |
| Gross Profit Ratio |
0 |
1 |
1 |
0.81 |
1 |
1 |
0.82 |
0.82 |
0.83 |
0.84 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$836,518.00
|
$219.86 M
|
$234.24 M
|
$0.00
|
$235.91 M
|
$234.24 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$220,000.00
|
$234,000.00
|
$234.69 M
|
$236,000.00
|
$234,000.00
|
$253,000.00
|
$253,000.00
|
$263,000.00
|
$290.59 M
|
| Selling, General &
Administrative Expenses |
$836,518.00
|
$220.08 M
|
$234.47 M
|
$234.69 M
|
$236.15 M
|
$234.47 M
|
$253,000.00
|
$253,000.00
|
$263,000.00
|
$290.59 M
|
| Other Expenses |
$0.00 |
$635.37 M |
$658.00 M |
$787.48 M |
$680.10 M |
$658.52 M |
$656,000.00 |
$682,000.00 |
$724,000.00 |
$870.84 M |
| Operating Expenses |
$836,518.00 |
$855.45 M |
$892.47 M |
$1.02 B |
$916.25 M |
$892.99 M |
$909,000.00 |
$935,000.00 |
$987,000.00 |
$1.16 B |
| Cost And Expenses |
$836,518.00 |
$855.63 M |
$892.66 M |
$1.20 B |
$916.42 M |
$893.16 M |
$1.09 M |
$1.11 M |
$1.18 M |
$1.34 B |
| Interest Income |
$60,533.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$60,533.00 |
$68.03 M |
$84.13 M |
$81.34 M |
$89.46 M |
$87.91 M |
$91,000.00 |
$75,000.00 |
$92,000.00 |
$109.29 M |
| Depreciation &
Amortization |
$5.74 M
|
$86.24 M
|
$83.92 M
|
$86.95 M
|
$81.10 M
|
$89.81 M
|
$89.04 M
|
$109.50 M
|
$127.22 M
|
$136.13 M
|
| EBITDA |
$4.90 M
|
$204.65 M
|
$174.34 M
|
$22.11 M
|
$129.72 M
|
$63.08 M
|
$89.14 M
|
$109.57 M
|
$127.32 M
|
$213.36 M
|
| EBITDA Ratio |
0 |
0.21 |
0.17 |
0.02 |
0.13 |
0.06 |
88.69 |
109.68 |
113.88 |
0.19 |
| Operating Income Ratio
|
0
|
0.12
|
0.09
|
-0.07
|
0.05
|
-0.03
|
0.09
|
0.07
|
0.09
|
0.07
|
| Total Other
Income/Expenses Net |
$5.68 M
|
-$65.94 M
|
-$84.13 M
|
-$83.32 M
|
-$87.88 M
|
$24.47 M
|
-$91,000.00
|
-$75,000.00
|
$3,000.00
|
-$234.06 M
|
| Income Before Tax |
$4.84 M |
$52.47 M |
$6.29 M |
-$148.16 M |
-$39.26 M |
-$2.26 M |
$4,000.00 |
-$9,000.00 |
$99,000.00 |
-$156.83 M |
| Income Before Tax Ratio
|
0
|
0.05
|
0.01
|
-0.16
|
-0.04
|
-0
|
0
|
-0.01
|
0.09
|
-0.14
|
| Income Tax Expense |
-$5.74 M |
$4.18 M |
$1.11 M |
-$18.49 M |
$6.73 M |
$15.12 M |
-$3,000.00 |
$8,000.00 |
-$39,000.00 |
$64.82 M |
| Net Income |
$10.58 M |
$48.29 M |
$5.18 M |
-$129.67 M |
-$45.99 M |
-$17.38 M |
$7,000.00 |
-$17,000.00 |
$138,000.00 |
-$221.65 M |
| Net Income Ratio |
0 |
0.05 |
0.01 |
-0.14 |
-0.05 |
-0.02 |
0.01 |
-0.02 |
0.12 |
-0.2 |
| EPS |
0.47 |
1.19 |
0.13 |
-3.26 |
-1.17 |
-0.45 |
0.0002 |
-0.0005 |
0.0043 |
-7.22 |
| EPS Diluted |
0.47 |
1.17 |
0.13 |
-3.26 |
-1.17 |
-0.45 |
0.0002 |
-0.0005 |
0.0043 |
-7.22 |
| Weighted Average Shares
Out |
$22.62 M
|
$40.69 M
|
$39.96 M
|
$39.73 M
|
$39.34 M
|
$38.75 M
|
$32.72 M
|
$32.18 M
|
$32.18 M
|
$30.70 M
|
| Weighted Average Shares
Out Diluted |
$22.62 M
|
$41.32 M
|
$40.32 M
|
$39.73 M
|
$39.34 M
|
$38.75 M
|
$32.72 M
|
$32.18 M
|
$32.18 M
|
$30.70 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
